{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T16:54:09Z","timestamp":1790787249230,"version":"4.1.0"},"reference-count":90,"publisher":"Institute of Physiology of the Czech Academy of Sciences","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Physiol Res"],"abstract":"<jats:p>ADHD is a common chronic neurodevelopmental disorder and is characterized by persistent inattention, hyperactivity, impulsivity and are often accompanied by learning and memory impairment. Great evidence has shown that learning and memory impairment of ADHD plays an important role in its executive function deficits, which seriously affects the development of academic, cognitive and daily social skills and will cause a serious burden on families and society. With the increasing attention paid to learning and memory impairment in ADHD, relevant research is gradually increasing. In this article, we will present the current research results of learning and memory impairment in ADHD from the following aspects. Firstly, the animal models of ADHD, which display the core symptoms of ADHD as well as with learning and memory impairment. Secondly, the molecular mechanism of has explored, including some neurotransmitters, receptors, RNAs, etc. Thirdly, the susceptibility gene of ADHD related to the learning and impairment in order to have a more comprehensive understanding of the pathogenesis.\nKey words: Learning and memory \u2022 ADHD \u2022 Review<\/jats:p>","DOI":"10.33549\/physiolres.935202","type":"journal-article","created":{"date-parts":[[2024,5,2]],"date-time":"2024-05-02T08:15:11Z","timestamp":1714637711000},"page":"202-215","source":"Crossref","is-referenced-by-count":5,"title":["Learning and Memory Impairments With Attention-Deficit\/Hyperactivity Disorder"],"prefix":"10.33549","author":[{"given":"T","family":"Tian","sequence":"first","affiliation":[{"name":"Department of Children\u2019s Health Care, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Maternal and Child Health Care Hospital, Nanjing, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"19169","published-online":{"date-parts":[[2024,4,30]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"Andersen PN, Egeland J, \u00d8ie M. Learning and memory impairments in children and adolescents with attention-deficit\/hyperactivity disorder. J Learn Disabil 2013;46:453-460. https:\/\/doi.org\/10.1177\/0022219412437040","DOI":"10.1177\/0022219412437040"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"Austerman J. ADHD and behavioral disorders: Assessment, management, and an update from DSM-5. Cleve Clin J Med 2015;82: S2-7. https:\/\/doi.org\/10.3949\/ccjm.82.s1.01","DOI":"10.3949\/ccjm.82.s1.01"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"D'esposito M, Detre J A, Alsop D C, Shin R K, Atlas S, Grossman M. The neural basis of the central executive system of working memory. Nature 1995;378:279-281. https:\/\/doi.org\/10.1038\/378279a0","DOI":"10.1038\/378279a0"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Baddeley A. Working memory and language: an overview. J Commun Disord 2003;36:189-208. https:\/\/doi.org\/10.1016\/S0021-9924(03)00019-4","DOI":"10.1016\/S0021-9924(03)00019-4"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"Cohen R, Cohen-Kroitoru B, Halevy A, Aharoni S, Aizenberg I, Shuper A. Handwriting in children with Attention Deficient Hyperactive Disorder: role of graphology. BMC Pediatr 2019;19:484. https:\/\/doi.org\/10.1186\/s12887-019-1854-3","DOI":"10.1186\/s12887-019-1854-3"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"Tibu F, Sheridan MA, Mclaughlin K A, Nelson CA, Fox NA, Zeanah CH. Disruptions of working memory and inhibition mediate the association between exposure to institutionalization and symptoms of attention deficit hyperactivity disorder. Psychol Med 2016;46: 529-541. https:\/\/doi.org\/10.1017\/S0033291715002020","DOI":"10.1017\/s0033291715002020"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"Tibu F, Sheridan MA, Mclaughlin K A, Nelson C A, Fox N A, Zeanah CH. Reduced working memory mediates the link between early institutional rearing and symptoms of ADHD at 12 Years. Front Psychol 2016;7:1850. https:\/\/doi.org\/10.3389\/fpsyg.2016.01850","DOI":"10.3389\/fpsyg.2016.01850"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"Willcutt E G, Doyle A E, Nigg J T, Faraone S V, Pennington B F. Validity of the executive function theory of attention-deficit\/hyperactivity disorder: a meta-analytic review. Biol Psychiatry 2005;57:1336-1346. https:\/\/doi.org\/10.1016\/j.biopsych.2005.02.006","DOI":"10.1016\/j.biopsych.2005.02.006"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"Phillips MS, Bing-Canar H, Shields AN, Cerny B, Chang F, Wisinger AM, Leib S I, et al. Assessment of learning and memory impairments in adults with predominately inattentive versus combined presentation attention-deficit\/hyperactivity disorder. Appl Neuropsychol Adult 2023;1-10. https:\/\/doi.org\/10.1080\/23279095.2023.2169887","DOI":"10.1080\/23279095.2023.2169887"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"Peterson K, Mcdonagh M S, Fu R. Comparative benefits and harms of competing medications for adults with attention-deficit hyperactivity disorder: a systematic review and indirect comparison meta-analysis. Psychopharmacology (Berl) 2008;197:1-11. https:\/\/doi.org\/10.1007\/s00213-007-0996-4","DOI":"10.1007\/s00213-007-0996-4"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"Quinn D. Does chirality matter? pharmacodynamics of enantiomers of methylphenidate in patients with attention-deficit\/hyperactivity disorder. J Clin Psychopharmacol 2008;28:S62-S66. https:\/\/doi.org\/10.1097 \/JCP.0b013e3181744aa6","DOI":"10.1097\/jcp.0b013e3181744aa6"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"Li J, Wang Y, Zhou R, Zhang H, Yang L, Wang B, Khan S, et al. Serotonin 5-HT1B receptor gene and attention deficit hyperactivity disorder in Chinese Han subjects. Am J Med Genet B Neuropsychiatr Genet 2005;132b:59-63. https:\/\/doi.org\/10.1002\/ajmg.b.30075","DOI":"10.1002\/ajmg.b.30075"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"Jensen V, Rinholm J E, Johansen T J, Medin T, Storm-Mathisen J, Sagvolden T, Hvalby O, et al. N-methyl-D-aspartate receptor subunit dysfunction at hippocampal glutamatergic synapses in an animal model of attention-deficit\/hyperactivity disorder. Neuroscience 2009;158: 353-364. https:\/\/doi.org\/10.1016\/j.neuroscience.2008.05.016","DOI":"10.1016\/j.neuroscience.2008.05.016"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"Corominas-Roso M, Ramos-Quiroga J A, Ribases M, Sanchez-Mora C, Palomar G, Valero S, Bosch R, et al. Decreased serum levels of brain-derived neurotrophic factor in adults with attention-deficit hyperactivity disorder. Int J Neuropsychopharmacol 2013;16: 1267-1275. https:\/\/doi.org\/10.1017\/S1461145712001629","DOI":"10.1017\/s1461145712001629"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"Eilertsen E M, Gjerde L C, Kendler K S, R\u00f8ysamb E, Aggen S H, Gustavson K, Reichborn-Kjennerud T, et al. Development of ADHD symptoms in preschool children: Genetic and environmental contributions. Dev Psychopathol 2019;31: 1299-1305. https:\/\/doi.org\/10.1017\/S0954579418000731","DOI":"10.1017\/s0954579418000731"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"Kian N, Samieefar N, Rezaei N. Prenatal risk factors and genetic causes of ADHD in children. World J Pediatr 2022;18: 308-319. https:\/\/doi.org\/10.1007\/s12519-022-00524-6","DOI":"10.1007\/s12519-022-00524-6"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"Faraone S V, Larsson H. Genetics of attention deficit hyperactivity disorder. Mol Psychiatry 2019;24:562-575. https:\/\/doi.org\/10.1038\/s41380-018-0070-0","DOI":"10.1038\/s41380-018-0070-0"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"Ochozkov\u00e1 A, Mihal\u010d\u00edkov\u00e1 L, Yamamotov\u00e1 A, \u0160lamberov\u00e1 R. Can prenatal methamphetamine exposure be considered a good animal model for ADHD? Physiol Res 2021;70: S431-s440. https:\/\/doi.org\/10.33549\/physiolres.934815","DOI":"10.33549\/physiolres.934815"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"Regan S L, Williams M T, Vorhees C V. Review of rodent models of attention deficit hyperactivity disorder. Neurosci Biobehav Rev 2022;132:621-637. https:\/\/doi.org\/10.1016\/j.neubiorev.2021.11.041","DOI":"10.1016\/j.neubiorev.2021.11.041"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"Meneses A, Perez-Garcia G, Ponce-Lopez T, Tellez R, Gallegos-Cari A, Castillo C. Spontaneously hypertensive rat (SHR) as an animal model for ADHD: a short overview. Rev Neurosci 2011;22: 365-371. https:\/\/doi.org\/10.1515\/rns.2011.024","DOI":"10.1515\/rns.2011.024"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"Kishikawa Y, Kawahara Y, Yamada M, Kaneko F, Kawahara H, Nishi A. The spontaneously hypertensive rat\/Izm (SHR\/Izm) shows attention deficit\/hyperactivity disorder-like behaviors but without impulsive behavior: therapeutic implications of low-dose methylphenidate. Behav Brain Res 2014;274: 235-242. https:\/\/doi.org\/10.1016\/j.bbr.2014.08.026","DOI":"10.1016\/j.bbr.2014.08.026"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"Oades R D, Sadile A G, Sagvolden T, Viggiano D, Zuddas A, Devoto P, Aase H, et al. The control of responsiveness in ADHD by catecholamines: evidence for dopaminergic, noradrenergic and interactive roles. Dev Sci 2005;8:122-31. https:\/\/doi.org\/10.1111\/j.1467-7687.2005.00399.x","DOI":"10.1111\/j.1467-7687.2005.00399.x"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"Miller E M, Pomerleau F, Huettl P, Gerhardt G A, Glaser P E. Aberrant glutamate signaling in the prefrontal cortex and striatum of the spontaneously hypertensive rat model of attention-deficit\/hyperactivity disorder. Psychopharmacology (Berl) 2014;231: 3019-29. https:\/\/doi.org\/10.1007\/s00213-014-3479-4","DOI":"10.1007\/s00213-014-3479-4"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"Sterley T L, Howells F M, Russell V A. Genetically determined differences in noradrenergic function: The spontaneously hypertensive rat model. Brain Res 2016;1641:291-305. https:\/\/doi.org\/10.1016\/j.brainres.2015.11.019","DOI":"10.1016\/j.brainres.2015.11.019"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"Fasmer O B, Johansen E B. Patterns of motor activity in spontaneously hypertensive rats compared to Wistar Kyoto rats. Behav Brain Funct 2016;12:32. https:\/\/doi.org\/10.1186\/s12993-016-0117-9","DOI":"10.1186\/s12993-016-0117-9"},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"Nakamura-Palacios E M, Caldas C K, Fiorini A, Chagas K D, Chagas K N, Vasquez E C. Deficits of spatial learning and working memory in spontaneously hypertensive rats. Behav Brain Res 1996;74: 217-227. https:\/\/doi.org\/10.1016\/0166-4328(95)00165-4","DOI":"10.1016\/0166-4328(95)00165-4"},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"Yuan H, Ni X, Zheng M, Han X, Song Y, Yu M. Effect of catalpol on behavior and neurodevelopment in an ADHD rat model. Biomed Pharmacother 2019;118: 109033. https:\/\/doi.org\/10.1016\/j.biopha.2019.109033","DOI":"10.1016\/j.biopha.2019.109033"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"Mereu M, Contarini G, Buonaguro E F, Latte G, Manag\u00f2 F, Iasevoli F, De Bartolomeis A, et al. Dopamine transporter (DAT) genetic hypofunction in mice produces alterations consistent with ADHD but not schizophrenia or bipolar disorder. Neuropharmacology 2017;121: 179-194. https:\/\/doi.org\/10.1016\/j.neuropharm.2017.04.037","DOI":"10.1016\/j.neuropharm.2017.04.037"},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"Takamatsu Y, Hagino Y, Sato A, Takahashi T, Nagasawa S Y, Kubo Y, Mizuguchi M, et al. Improvement of learning and increase in dopamine level in the frontal cortex by methylphenidate in mice lacking dopamine transporter. Curr Mol Med 2015;15: 245-52. https:\/\/doi.org\/10.2174\/1566524015666150330144018","DOI":"10.2174\/1566524015666150330144018"},{"key":"ref29","doi-asserted-by":"publisher","unstructured":"Zhu X, Li T, Peng S, Ma X, Chen X, Zhang X. Maternal deprivation-caused behavioral abnormalities in adult rats relate to a non-methylation-regulated D2 receptor levels in the nucleus accumbens. Behav Brain Res 2010;209:281-288. https:\/\/doi.org\/10.1016\/j.bbr.2010.02.005","DOI":"10.1016\/j.bbr.2010.02.005"},{"key":"ref30","doi-asserted-by":"publisher","unstructured":"Morice E, Denis C, Giros B, Nosten-Bertrand M. Phenotypic expression of the targeted null-mutation in the dopamine transporter gene varies as a function of the genetic background. Eur J Neurosci 2004;20:120-126. https:\/\/doi.org\/10.1111\/j.1460-9568.2004.03465.x","DOI":"10.1111\/j.1460-9568.2004.03465.x"},{"key":"ref31","doi-asserted-by":"publisher","unstructured":"Meza-Aguilar D G, Boucard A A. Latrophilins updated. Biomol Concepts 2014;5:457-478. https:\/\/doi.org\/10.1515\/bmc-2014-0032","DOI":"10.1515\/bmc-2014-0032"},{"key":"ref32","doi-asserted-by":"publisher","unstructured":"\u00d6zaslan A, G\u00fcney E, Erg\u00fcn M A, Okur \u0130, Yapar D. CDH13 and LPHN3 gene polymorphisms in attention-deficit\/hyperactivity disorder: their relation to clinical characteristics. J Mol Neurosci 2021;71: 394-408. https:\/\/doi.org\/10.1007\/s12031-020-01662-0","DOI":"10.1007\/s12031-020-01662-0"},{"key":"ref33","doi-asserted-by":"publisher","unstructured":"Regan S L, Pitzer E M, Hufgard J R, Sugimoto C, Williams M T, Vorhees C V. A novel role for the ADHD risk gene latrophilin-3 in learning and memory in Lphn3 knockout rats. Neurobiol Dis 2021;158: 105456. https:\/\/doi.org\/10.1016\/j.nbd.2021.105456","DOI":"10.1016\/j.nbd.2021.105456"},{"key":"ref34","doi-asserted-by":"publisher","unstructured":"Regan S L, Hufgard J R, Pitzer E M, Sugimoto C, Hu Y C, Williams M T, Vorhees C V. Knockout of latrophilin-3 in Sprague-Dawley rats causes hyperactivity, hyper-reactivity, under-response to amphetamine, and disrupted dopamine markers. Neurobiol Dis 2019;130:104494. https:\/\/doi.org\/10.1016\/j.nbd.2019.104494","DOI":"10.1016\/j.nbd.2019.104494"},{"key":"ref35","doi-asserted-by":"publisher","unstructured":"Fallgatter A J, Ehlis A C, Dresler T, Reif A, Jacob C P, Arcos-Burgos M, Muenke M, et al. Influence of a latrophilin 3 (LPHN3) risk haplotype on event-related potential measures of cognitive response control in attention-deficit hyperactivity disorder (ADHD). Eur Neuropsychopharmacol 2013;23:458-468. https:\/\/doi.org\/10.1016\/j.euroneuro.2012.11.001","DOI":"10.1016\/j.euroneuro.2012.11.001"},{"key":"ref36","doi-asserted-by":"publisher","unstructured":"Li X, Wu X, Luo P, Xiong L. Astrocyte-specific NDRG2 gene: functions in the brain and neurological diseases. Cell Mol Life Sci 2020;77 2461-2472. https:\/\/doi.org\/10.1007\/s00018-019-03406-9","DOI":"10.1007\/s00018-019-03406-9"},{"key":"ref37","doi-asserted-by":"publisher","unstructured":"Li Y, Yin A, Sun X, Zhang M, Zhang J, Wang P, Xie R, et al. Deficiency of tumor suppressor NDRG2 leads to attention deficit and hyperactive behavior. J Clin Invest 2017;127: 4270-4284. https:\/\/doi.org\/10.1172\/JCI94455","DOI":"10.1172\/jci94455"},{"key":"ref38","doi-asserted-by":"publisher","unstructured":"Rhodes S M, Coghill D R, Matthews K. Methylphenidate restores visual memory, but not working memory function in attention deficit-hyperkinetic disorder. Psychopharmacology (Berl) 2004;175: 319-330. https:\/\/doi.org\/10.1007\/s00213-004-1833-7","DOI":"10.1007\/s00213-004-1833-7"},{"key":"ref39","doi-asserted-by":"publisher","unstructured":"Kang A M, Palmatier M A, Kidd K K. Global variation of a 40-bp VNTR in the 3'-untranslated region of the dopamine transporter gene (SLC6A3). Biol Psychiatry 1999;46: 151-160. https:\/\/doi.org\/10.1016\/S0006-3223(99)00101-8","DOI":"10.1016\/s0006-3223(99)00101-8"},{"key":"ref40","doi-asserted-by":"publisher","unstructured":"Zuschlag Z D, Compean E, Nietert P, Lauzon S, Hamner M, Wang Z. Dopamine transporter (DAT1) gene in combat veterans with PTSD: A case-control study. Psychiatry Res 2021;298: 113801. https:\/\/doi.org\/10.1016\/j.psychres.2021.113801","DOI":"10.1016\/j.psychres.2021.113801"},{"key":"ref41","doi-asserted-by":"publisher","unstructured":"Bacanl\u0131 A, Unsel-Bolat G, Suren S, Yaz\u0131c\u0131 K U, Call\u0131 C, Aygunes Jafari D, Kosova B, et al. Effects of the dopamine transporter gene on neuroimaging findings in different attention deficit hyperactivity disorder presentations. Brain Imaging Behav 2021;15: 1103-1114. https:\/\/doi.org\/10.1007\/s11682-020-00437-w","DOI":"10.1007\/s11682-020-00437-w"},{"key":"ref42","doi-asserted-by":"publisher","unstructured":"Brown A B, Biederman J, Valera E, Makris N, Doyle A, Whitfield-Gabrieli S, Mick E, et al. Relationship of DAT1 and adult ADHD to task-positive and task-negative working memory networks. Psychiatry Res 2011;193:7-16. https:\/\/doi.org\/10.1016\/j.pscychresns.2011.01.006","DOI":"10.1016\/j.pscychresns.2011.01.006"},{"key":"ref43","doi-asserted-by":"publisher","unstructured":"Li Q, Lu G, Antonio G E, Mak Y T, Rudd J A, Fan M, Yew D T. The usefulness of the spontaneously hypertensive rat to model attention-deficit\/hyperactivity disorder (ADHD) may be explained by the differential expression of dopamine-related genes in the brain. Neurochem Int 2007;50: 848-857. https:\/\/doi.org\/10.1016\/j.neuint.2007.02.005","DOI":"10.1016\/j.neuint.2007.02.005"},{"key":"ref44","doi-asserted-by":"publisher","unstructured":"Yin P, Cao A H, Yu L, Guo L J, Sun R P, Lei G F. ABT-724 alleviated hyperactivity and spatial learning impairment in the spontaneously hypertensive rat model of attention-deficit\/hyperactivity disorder. Neurosci Lett 2014;580:142-146. https:\/\/doi.org\/10.1016\/j.neulet.2014.08.008","DOI":"10.1016\/j.neulet.2014.08.008"},{"key":"ref45","doi-asserted-by":"publisher","unstructured":"Loo S K, Rich E C, Ishii J, Mcgough J, Mccracken J, Nelson S, Smalley S L. Cognitive functioning in affected sibling pairs with ADHD: familial clustering and dopamine genes. J Child Psychol Psychiatry 2008;49:950-957. https:\/\/doi.org\/10.1111\/j.1469-7610.2008.01928.x","DOI":"10.1111\/j.1469-7610.2008.01928.x"},{"key":"ref46","doi-asserted-by":"publisher","unstructured":"Brookes K J, Xu X, Chen C K, Huang Y S, Wu Y Y, Asherson P. No evidence for the association of DRD4 with ADHD in a Taiwanese population within-family study. BMC Med Genet 2005;6: 31. https:\/\/doi.org\/10.1186\/1471-2350-6-31","DOI":"10.1186\/1471-2350-6-31"},{"key":"ref47","doi-asserted-by":"publisher","unstructured":"Schaefer T L, Vorhees C V, Williams M T. Mouse plasmacytoma-expressed transcript 1 knock out induced 5-HT disruption results in a lack of cognitive deficits and an anxiety phenotype complicated by hypoactivity and defensiveness. Neuroscience 2009;164:1431-1443. https:\/\/doi.org\/10.1016\/j.neuroscience.2009.09.059","DOI":"10.1016\/j.neuroscience.2009.09.059"},{"key":"ref48","doi-asserted-by":"crossref","unstructured":"Gonz\u00e1lez-Burgos I, Feria-Velasco A. Serotonin\/dopamine interaction in memory formation. Prog Brain Res 2008;172: 603-623. https:\/\/doi.org\/10.1016\/S0079-6123(08)00928-X","DOI":"10.1016\/S0079-6123(08)00928-X"},{"key":"ref49","doi-asserted-by":"publisher","unstructured":"Salman T, Nawaz S, Waraich R S, Haleem D J. Repeated administration of methylphenidate produces reinforcement and downregulates 5-HT-1A receptor expression in the nucleus accumbens. Life Sci 2019;218:139-146. https:\/\/doi.org\/10.1016\/j.lfs.2018.12.046","DOI":"10.1016\/j.lfs.2018.12.046"},{"key":"ref50","doi-asserted-by":"publisher","unstructured":"Salman T, Afroz R, Nawaz S, Mahmood K, Haleem D J, Zarina S. Differential effects of memory enhancing and impairing doses of methylphenidate on serotonin metabolism and 5-HT1A, GABA, glutamate receptor expression in the rat prefrontal cortex. Biochimie 2021;191:51-61. https:\/\/doi.org\/10.1016\/j.biochi.2021.08.009","DOI":"10.1016\/j.biochi.2021.08.009"},{"key":"ref51","doi-asserted-by":"publisher","unstructured":"Zepf FD, Landgraf M, Biskup C S, Dahmen B, Poustka F, W\u00f6ckel L, Stadler C. No effect of acute tryptophan depletion on verbal declarative memory in young persons with ADHD. Acta Psychiatr Scand 2013;128:133-141. https:\/\/doi.org\/10.1111\/acps.12089","DOI":"10.1111\/acps.12089"},{"key":"ref52","doi-asserted-by":"publisher","unstructured":"Huang X, Wang M, Zhang Q, Chen X, Wu J. The role of glutamate receptors in attention-deficit\/hyperactivity disorder: From physiology to disease. Am J Med Genet B Neuropsychiatr Genet 2019;180: 272-286. https:\/\/doi.org\/10.1002\/ajmg.b.32726","DOI":"10.1002\/ajmg.b.32726"},{"key":"ref53","doi-asserted-by":"publisher","unstructured":"Maltezos S, Horder J, Coghlan S, Skirrow C, O'gorman R, Lavender T J, Mendez M A, et al. Glutamate\/glutamine and neuronal integrity in adults with ADHD: a proton MRS study. Transl Psychiatry 2014;4: e373. https:\/\/doi.org\/10.1038\/tp.2014.11","DOI":"10.1038\/tp.2014.11"},{"key":"ref54","doi-asserted-by":"publisher","unstructured":"Bauer J, Werner A, Kohl W, Kugel H, Shushakova A, Pedersen A, Ohrmann P. Hyperactivity and impulsivity in adult attention-deficit\/hyperactivity disorder is related to glutamatergic dysfunction in the anterior cingulate cortex. World J Biol Psychiatry 2018;19: 538-546. https:\/\/doi.org\/10.1080\/15622975.2016.1262060","DOI":"10.1080\/15622975.2016.1262060"},{"key":"ref55","doi-asserted-by":"publisher","unstructured":"Hiraoka Y, Sugiyama K, Nagaoka D, Tsutsui-Kimura I, Tanaka K F, Tanaka K. Mice with reduced glutamate transporter GLT1 expression exhibit behaviors related to attention-deficit\/hyperactivity disorder. Biochem Biophys Res Commun 2021;567: 161-165. https:\/\/doi.org\/10.1016\/j.bbrc.2021.06.057","DOI":"10.1016\/j.bbrc.2021.06.057"},{"key":"ref56","doi-asserted-by":"publisher","unstructured":"Shikanai H, Oshima N, Kawashima H, Kimura SI, Hiraide S, Togashi H, Iizuka K, et al. N-methyl-d-aspartate receptor dysfunction in the prefrontal cortex of stroke-prone spontaneously hypertensive rat\/Ezo as a rat model of attention deficit\/hyperactivity disorder. Neuropsychopharmacol Rep 2018;38:61-66. https:\/\/doi.org\/10.1002\/npr2.12007","DOI":"10.1002\/npr2.12007"},{"key":"ref57","doi-asserted-by":"publisher","unstructured":"Cheng J, Xiong Z, Duffney LJ, Wei J, Liu A, Liu S, Chen GJ, et al. Methylphenidate exerts dose-dependent effects on glutamate receptors and behaviors. Biol Psychiatry 2014;76: 953-962. https:\/\/doi.org\/10.1016\/j.biopsych.2014.04.003","DOI":"10.1016\/j.biopsych.2014.04.003"},{"key":"ref58","doi-asserted-by":"publisher","unstructured":"Kawade HM, Borkar CD, Shambharkar AS, Singh O, Singru PS, Subhedar NK, Kokare DM. Intracellular mechanisms and behavioral changes in mouse model of attention deficit hyperactivity disorder: Importance of age-specific NMDA receptor blockade. Pharmacol Biochem Behav 2020;188: 172830. https:\/\/doi.org\/10.1016\/j.pbb.2019.172830","DOI":"10.1016\/j.pbb.2019.172830"},{"key":"ref59","doi-asserted-by":"publisher","unstructured":"Wilens T E, Decker M W. Neuronal nicotinic receptor agonists for the treatment of attention-deficit\/hyperactivity disorder: focus on cognition. Biochem Pharmacol 2007;74: 1212-1223. https:\/\/doi.org\/10.1016\/j.bcp.2007.07.002","DOI":"10.1016\/j.bcp.2007.07.002"},{"key":"ref60","doi-asserted-by":"publisher","unstructured":"Guo T, Yang C, Guo L, Liu K. A comparative study of the effects of ABT-418 and methylphenidate on spatial memory in an animal model of ADHD. Neurosci Lett 2012;528: 11-15. https:\/\/doi.org\/10.1016\/j.neulet.2012.08.068","DOI":"10.1016\/j.neulet.2012.08.068"},{"key":"ref61","doi-asserted-by":"publisher","unstructured":"Jeong H I, Ji E S, Kim S H, Kim T W, Baek S B, Choi S W. Treadmill exercise improves spatial learning ability by enhancing brain-derived neurotrophic factor expression in the attention-deficit\/hyperactivity disorder rats. J Exerc Rehabil 2014;10:162-167. https:\/\/doi.org\/10.12965\/jer.140111","DOI":"10.12965\/jer.140111"},{"key":"ref62","doi-asserted-by":"publisher","unstructured":"Wilens T E, Verlinden M H, Adler L A, Wozniak P J, West S A. ABT-089, a neuronal nicotinic receptor partial agonist, for the treatment of attention-deficit\/hyperactivity disorder in adults: results of a pilot study. Biol Psychiatry 2006;59: 1065-1070. https:\/\/doi.org\/10.1016\/j.biopsych.2005.10.029","DOI":"10.1016\/j.biopsych.2005.10.029"},{"key":"ref63","doi-asserted-by":"publisher","unstructured":"Lu B, Nagappan G, Lu Y. BDNF and synaptic plasticity, cognitive function, and dysfunction. Handb Exp Pharmacol 2014;220 223-250. https:\/\/doi.org\/10.1007\/978-3-642-45106-5_9","DOI":"10.1007\/978-3-642-45106-5_9"},{"key":"ref64","doi-asserted-by":"publisher","unstructured":"Wang L J, Wu C C, Lee M J, Chou M C, Lee S Y, Chou W J. Peripheral brain-derived neurotrophic factor and contactin-1 levels in patients with attention-deficit\/hyperactivity disorder. J Clin Med 2019;8. https:\/\/doi.org\/10.3390\/jcm8091366","DOI":"10.3390\/jcm8091366"},{"key":"ref65","doi-asserted-by":"crossref","unstructured":"Kasem E, Kurihara T, Tabuchi K. Neurexins and neuropsychiatric disorders. Neurosci Res 2018;127: 53-60. https:\/\/doi.org\/10.1016\/j.neures.2017.10.012","DOI":"10.1016\/j.neures.2017.10.012"},{"key":"ref66","doi-asserted-by":"publisher","unstructured":"Zhang S, Wu D, Xu Q, You L, Zhu J, Wang J, Liu Z, et al. The protective effect and potential mechanism of NRXN1 on learning and memory in ADHD rat models. Exp Neurol 2021;344:113806. https:\/\/doi.org\/10.1016\/j.expneurol.2021.113806","DOI":"10.1016\/j.expneurol.2021.113806"},{"key":"ref67","doi-asserted-by":"publisher","unstructured":"Luo P, Li X, Fei Z, Poon W. Scaffold protein Homer 1: implications for neurological diseases. Neurochem Int 2012;61:731-738. https:\/\/doi.org\/10.1016\/j.neuint.2012.06.014","DOI":"10.1016\/j.neuint.2012.06.014"},{"key":"ref68","doi-asserted-by":"publisher","unstructured":"Hong Q, Wang Y P, Zhang M, Pan X Q, Guo M, Li F, Tong M L, et al. Homer expression in the hippocampus of an animal model of attention-deficit\/hyperactivity disorder. Mol Med Rep 2011;4:705-712.","DOI":"10.3892\/mmr.2011.479"},{"key":"ref69","doi-asserted-by":"publisher","unstructured":"Salatino-Oliveira A, Genro J P, Polanczyk G, Zeni C, Schmitz M, Kieling C, Anselmi L, et al. Cadherin-13 gene is associated with hyperactive\/impulsive symptoms in attention\/deficit hyperactivity disorder. Am J Med Genet B Neuropsychiatr Genet 2015;168b: 162-169. https:\/\/doi.org\/10.1002\/ajmg.b.32293","DOI":"10.1002\/ajmg.b.32293"},{"key":"ref70","doi-asserted-by":"publisher","unstructured":"Ziegler G C, Ehlis A C, Weber H, Vitale M R, Z\u00f6ller J E M, Ku H P, Schiele M A, et al. A common CDH13 variant is associated with low agreeableness and neural responses to working memory tasks in ADHD. Genes (Basel) 2021;12. https:\/\/doi.org\/10.3390\/genes12091356","DOI":"10.3390\/genes12091356"},{"key":"ref71","doi-asserted-by":"publisher","unstructured":"Rivero O, Selten M M, Sich S, Popp S, Bacmeister L, Amendola E, Negwer M, et al. Cadherin-13, a risk gene for ADHD and comorbid disorders, impacts GABAergic function in hippocampus and cognition. Transl Psychiatry 2015;5:e655. https:\/\/doi.org\/10.1038\/tp.2015.152","DOI":"10.1038\/tp.2015.152"},{"key":"ref72","doi-asserted-by":"publisher","unstructured":"Forero A, Rivero O, W\u00e4ldchen S, Ku H P, Kiser D P, G\u00e4rtner Y, Pennington L S, et al. Cadherin-13 deficiency increases dorsal raphe 5-ht neuron density and prefrontal cortex innervation in the mouse brain. Front Cell Neurosci 2017;11: 307. https:\/\/doi.org\/10.3389\/fncel.2017.00307","DOI":"10.3389\/fncel.2017.00307"},{"key":"ref73","doi-asserted-by":"publisher","unstructured":"Shin E Y, Lee C S, Cho T G, Kim Y G, Song S, Juhnn Y S, Park S C, et al. betaPak-interacting exchange factor-mediated Rac1 activation requires smgGDS guanine nucleotide exchange factor in basic fibroblast growth factor-induced neurite outgrowth. J Biol Chem 2006;281: 35954-64. https:\/\/doi.org\/10.1074\/jbc.M602399200","DOI":"10.1074\/jbc.m602399200"},{"key":"ref74","doi-asserted-by":"publisher","unstructured":"Mccaffrey T A, St Laurent G, 3rd, Shtokalo D, Antonets D, Vyatkin Y, Jones D, Battison E, et al. Biomarker discovery in attention deficit hyperactivity disorder: RNA sequencing of whole blood in discordant twin and case-controlled cohorts. BMC Med Genomics 2020;13:160. https:\/\/doi.org\/10.1186\/s12920-020-00808-8","DOI":"10.1186\/s12920-020-00808-8"},{"key":"ref75","doi-asserted-by":"publisher","unstructured":"Martyn A C, Toth K, Schmalzigaug R, Hedrick N G, Rodriguiz R M, Yasuda R, Wetsel W C, et al. GIT1 regulates synaptic structural plasticity underlying learning. PLoS One 2018;13:e0194350. https:\/\/doi.org\/10.1371\/journal.pone.0194350","DOI":"10.1371\/journal.pone.0194350"},{"key":"ref76","doi-asserted-by":"publisher","unstructured":"Won H, Mah W, Kim E, Kim J W, Hahm E K, Kim M H, Cho S, et al. GIT1 is associated with ADHD in humans and ADHD-like behaviors in mice. Nat Med 2011;17: 566-572. https:\/\/doi.org\/10.1038\/nm.2330","DOI":"10.1038\/nm.2330"},{"key":"ref77","doi-asserted-by":"publisher","unstructured":"Couto J M, Gomez L, Wigg K, Ickowicz A, Pathare T, Malone M, Kennedy J L, et al. Association of attention-deficit\/hyperactivity disorder with a candidate region for reading disabilities on chromosome 6p. Biol Psychiatry 2009;66: 368-75. https:\/\/doi.org\/10.1016\/j.biopsych.2009.02.016","DOI":"10.1016\/j.biopsych.2009.02.016"},{"key":"ref78","doi-asserted-by":"publisher","unstructured":"Willcutt E G, Pennington B F, Smith S D, Cardon L R, Gay\u00e1n J, Knopik V S, Olson R K, et al. Quantitative trait locus for reading disability on chromosome 6p is pleiotropic for attention-deficit\/hyperactivity disorder. Am J Med Genet 2002;114:260-268. https:\/\/doi.org\/10.1002\/ajmg.10205","DOI":"10.1002\/ajmg.10205"},{"key":"ref79","doi-asserted-by":"publisher","unstructured":"Gabel L A, Marin I, Loturco J J, Che A, Murphy C, Manglani M, Kass S. Mutation of the dyslexia-associated gene Dcdc2 impairs LTM and visuo-spatial performance in mice. Genes Brain Behav 2011;10: 868-875. https:\/\/doi.org\/10.1111\/j.1601-183X.2011.00727.x","DOI":"10.1111\/j.1601-183x.2011.00727.x"},{"key":"ref80","doi-asserted-by":"publisher","unstructured":"Matilla A, Roberson E D, Banfi S, Morales J, Armstrong D L, Burright E N, Orr H T, et al. Mice lacking ataxin-1 display learning deficits and decreased hippocampal paired-pulse facilitation. J Neurosci 1998;18: 5508-5516. https:\/\/doi.org\/10.1523\/JNEUROSCI.18-14-05508.1998","DOI":"10.1523\/jneurosci.18-14-05508.1998"},{"key":"ref81","doi-asserted-by":"publisher","unstructured":"Rizzi T S, Arias-Vasquez A, Rommelse N, Kuntsi J, Anney R, Asherson P, Buitelaar J, et al. The ATXN1 and TRIM31 genes are related to intelligence in an ADHD background: evidence from a large collaborative study totaling 4,963 subjects. Am J Med Genet B Neuropsychiatr Genet 2011;156:145-157. https:\/\/doi.org\/10.1002\/ajmg.b.31149","DOI":"10.1002\/ajmg.b.31149"},{"key":"ref82","doi-asserted-by":"crossref","unstructured":"Lu H C, Tan Q, Rousseaux M W, Wang W, Kim J Y, Richman R, Wan Y W, et al. Disruption of the ATXN1-CIC complex causes a spectrum of neurobehavioral phenotypes in mice and humans. Nat Genet 2017;49: 527-536. https:\/\/doi.org\/10.1038\/ng.3808","DOI":"10.1038\/ng.3808"},{"key":"ref83","doi-asserted-by":"publisher","unstructured":"Celestino-Soper P B, Skinner C, Schroer R, Eng P, Shenai J, Nowaczyk M M, Terespolsky D, et al. Deletions in chromosome 6p22.3-p24.3, including ATXN1, are associated with developmental delay and autism spectrum disorders. Mol Cytogenet 2012;5:17. https:\/\/doi.org\/10.1186\/1755-8166-5-17","DOI":"10.1186\/1755-8166-5-17"},{"key":"ref84","doi-asserted-by":"publisher","unstructured":"Laatikainen L M, Sharp T, Harrison P J, Tunbridge E M. Sexually dimorphic effects of catechol-O-methyltransferase (COMT) inhibition on dopamine metabolism in multiple brain regions. PLoS One 2013;8: e61839. https:\/\/doi.org\/10.1371\/journal.pone.0061839","DOI":"10.1371\/journal.pone.0061839"},{"key":"ref85","doi-asserted-by":"publisher","unstructured":"Gothelf D, Michaelovsky E, Frisch A, Zohar A H, Presburger G, Burg M, Aviram-Goldring A, et al. Association of the low-activity COMT 158Met allele with ADHD and OCD in subjects with velocardiofacial syndrome. Int J Neuropsychopharmacol 2007;10:301-308. https:\/\/doi.org\/10.1017\/S1461145706006699","DOI":"10.1017\/s1461145706006699"},{"key":"ref86","doi-asserted-by":"crossref","unstructured":"Eisenberg J, Mei-Tal G, Steinberg A, Tartakovsky E, Zohar A, Gritsenko I, Nemanov L, et al. Haplotype relative risk study of catechol-O-methyltransferase (COMT) and attention deficit hyperactivity disorder (ADHD): association of the high-enzyme activity Val allele with ADHD impulsive-hyperactive phenotype. Am J Med Genet 1999;88: 497-502. https:\/\/doi.org\/10.1002\/(SICI)1096-8628(19991015)88:5<497::AID-AJMG12>3.0.CO;2-F","DOI":"10.1002\/(SICI)1096-8628(19991015)88:5<497::AID-AJMG12>3.0.CO;2-F"},{"key":"ref87","doi-asserted-by":"publisher","unstructured":"Jung M, Mizuno Y, Fujisawa T X, Takiguchi S, Kong J, Kosaka H, Tomoda A. The effects of COMT polymorphism on cortical thickness and surface area abnormalities in children with ADHD. Cereb Cortex 2019;29: 3902-3911. https:\/\/doi.org\/10.1093\/cercor\/bhy269","DOI":"10.1016\/j.jaac.2018.09.045"},{"key":"ref88","doi-asserted-by":"publisher","unstructured":"Jin J, Liu L, Gao Q, Chan R C, Li H, Chen Y, Wang Y, et al. The divergent impact of COMT Val158Met on executive function in children with and without attention-deficit\/hyperactivity disorder. Genes Brain Behav 2016;15:271-279. https:\/\/doi.org\/10.1111\/gbb.12270","DOI":"10.1111\/gbb.12270"},{"key":"ref89","doi-asserted-by":"publisher","unstructured":"Kang P, Luo L, Peng X, Wang Y. Association of Val158Met polymorphism in COMT gene with attention-deficit hyperactive disorder: An updated meta-analysis. Medicine (Baltimore) 2020;99: e23400. https:\/\/doi.org\/10.1097\/MD.0000000000023400","DOI":"10.1097\/md.0000000000023400"}],"container-title":["Physiological Research"],"original-title":[],"language":"en","deposited":{"date-parts":[[2024,5,2]],"date-time":"2024-05-02T08:15:20Z","timestamp":1714637720000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.biomed.cas.cz\/physiolres\/pdf\/2024\/73_205.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,30]]},"references-count":90,"URL":"https:\/\/doi.org\/10.33549\/physiolres.935202","relation":{},"ISSN":["1802-9973","0862-8408"],"issn-type":[{"value":"1802-9973","type":"electronic"},{"value":"0862-8408","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4,30]]}}}